- Report
- November 2023
- 353 Pages
Global
From €9149EUR$9,500USD£7,868GBP
- Report
- January 2021
- 900 Pages
United States
From €3178EUR$3,300USD£2,733GBP
- Report
- September 2021
- 40 Pages
China
From €2504EUR$2,600USD£2,153GBP
Aromasin (Exemestane) is a drug used to treat advanced stages of breast cancer in postmenopausal women. It is a type of hormone therapy, which works by blocking the production of estrogen in the body. Aromasin is also used to treat non-small cell lung cancer (NSCLC) in combination with other drugs. It is used to reduce the risk of cancer recurrence in patients who have already been treated with chemotherapy.
Aromasin is a prescription drug and is available in tablet form. It is manufactured by Pfizer, Inc. and is available in the United States, Canada, and other countries.
In the context of lung cancer drugs, Aromasin is used in combination with other drugs to treat NSCLC. It is used to reduce the risk of cancer recurrence in patients who have already been treated with chemotherapy. Aromasin is a prescription drug and is available in tablet form.
Companies in the Aromasin market include Pfizer, Inc., AstraZeneca, Novartis, and Merck & Co. Show Less Read more